Mdxhealth Announces Fourth Quarter and Full-Year 2025 Financial Results Feb 26, 2026 04:00PM
Mdxhealth to Present Fourth Quarter and Full Year 2025 Financial Results and Corporate Update on February 26 Feb 12, 2026 05:00PM
MDxHealth reports 21% revenue growth for 2025, issues 2026 guidance Jan 12, 2026 08:00AM
MDxHealth Reports Preliminary Fourth Quarter and Full Year 2025 Revenues, Issues 2026 Revenue Guidance, and Amends Earnout Terms with Exact Sciences Jan 12, 2026 08:00AM
Mdxhealth and University of Oxford to validate GPS test in largest randomized trial of treatment effectiveness in patients with localized prostate cancer Jan 6, 2026 08:00AM
View Older Stories

Nov 12, 2025 04:01PM Mdxhealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2025
Nov 3, 2025 04:01PM Mdxhealth to Release Third Quarter 2025 Financial Results on November 12
Sep 15, 2025 05:29PM Mdxhealth Announces Closing of Exosome Diagnostics Acquisition from Bio-Techne
Aug 5, 2025 04:01PM Mdxhealth Reports Preliminary Second Quarter 2025 Results, Reaches Positive Adjusted EBITDA, and Announces Acquisition of Exosome Diagnostics Business from Bio-Techne
Jul 3, 2025 01:00PM MDxHealth (MDXH) Appoints Michael Holder to Board of Directors and Announces Management Change
Jul 3, 2025 01:00PM Mdxhealth Appoints Michael Holder to Board of Directors and Announces Management Change
May 14, 2025 04:00PM MDxHealth Reports Q1-2025 Results
Apr 30, 2025 04:00PM Mdxhealth to Release First Quarter 2025 Financial Results on May 14
Feb 26, 2025 04:00PM Mdxhealth Announces Fourth Quarter and Full-Year 2024 Financial Results
Feb 12, 2025 04:00PM Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26
Jan 13, 2025 05:00AM MDxHealth Reports Preliminary Fourth Quarter and Full Year 2024 Revenues and Issues 2025 Revenue Guidance
Nov 25, 2024 08:30AM MDxHealth to Participate in Piper Sandler Healthcare Conference
Nov 6, 2024 04:00PM MDxHealth Reports Results for the Third Quarter and Nine-Month Period Ended September 30, 2024
Oct 14, 2024 08:00AM MDxHealth to Present Third Quarter 2024 Financial Results and Corporate Update on November 6
Aug 21, 2024 04:00PM MDxHealth Reports Q2 and Half Year 2024 Results
Aug 12, 2024 04:00PM MDxHealth to Present Second Quarter and First Half 2024 Financial Results and Corporate Update on August 21
Jul 8, 2024 08:00AM Mdxhealth Appoints Sanford J. Siegel, M.D. to Board of Directors
Jul 8, 2024 08:00AM MDxHealth Reports Preliminary Q2 and Half Year 2024 Revenues and Raises 2024 Revenue Guidance
May 15, 2024 04:00PM Mdxhealth to Present at Upcoming Investor Conferences
May 1, 2024 07:45AM MDxHealth Reports Q1-2024 Results and Announces Growth Capital from OrbiMed
Mar 12, 2024 04:00PM MDxHealth (MDXH) Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
Mar 12, 2024 04:00PM Mdxhealth Adds Hereditary Prostate Cancer Genetic Test to Prostate Cancer Offering
Mar 6, 2024 04:00PM Mdxhealth Announces Fourth Quarter and Full-Year 2023 Financial Results
Feb 21, 2024 05:00PM MDxHealth to Present Fourth Quarter and Full Year 2023 Financial Results and Corporate Update on March 6
Feb 16, 2024 08:46AM MDxHealth (MDXH) Announces Resignation of Jan Pensaert from Board
Feb 16, 2024 08:45AM Mdxhealth Announces Resignation of Board Member
Jan 8, 2024 04:00PM MDxHealth (MDXH) Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance
Jan 8, 2024 04:00PM MDxHealth Reports Preliminary Fourth Quarter and Full Year 2023 Revenues and Issues 2024 Revenue Guidance
Oct 25, 2023 04:00PM MDxHealth to Present Third Quarter 2023 Financial Results and Corporate Update on November 8
Oct 20, 2023 04:02PM MDxHealth's (MDXH) New Share Capital Amount and New Number of Shares
Oct 20, 2023 04:00PM Mdxhealth's New Share Capital Amount and New Number of Shares
Oct 9, 2023 04:00PM MDxHealth (MDXH) Reports Prelim Q3 Revenues
Oct 9, 2023 04:00PM MDxHealth Reports Preliminary Q3-2023 Revenues
Oct 2, 2023 04:04PM MDxHealth Announces Proposed Transition to a Sole Listing of Shares on Nasdaq and Convenes an Extraordinary General Shareholders Meeting
Sep 26, 2023 04:47PM MDxHealth (MDXH) Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer
Sep 26, 2023 04:46PM Mdxhealth Signs Research Collaboration with University of Oxford to Assess the Correlation of the GPS Test with Prostate Cancer Progression Following Treatment for Localized Prostate Cancer
May 23, 2023 04:00PM MDxHealth to Present at the 43rd Annual William Blair Growth Stock Conference
May 1, 2023 04:00PM MDxHealth to Present First Quarter 2023 Financial Results on May 15
Apr 25, 2023 04:00PM MDxHealth Announces its Ordinary and Extraordinary General Shareholders’ Meetings
Apr 19, 2023 04:00PM Foundational LCD Covers Select mdx for Prostate Cancer
Apr 10, 2023 05:52AM MDxHealth (MDXH) Issues Shareholder Transparency Declaration
Apr 7, 2023 04:30PM MDxHealth Shareholder Transparency Declaration
Mar 13, 2023 05:41AM MDxHealth (MDXH) Confirms No Exposure to Silicon Valley Bank or Silvergate Bank
Mar 13, 2023 02:00AM MDxHealth Confirms No Exposure to Silicon Valley Bank or Silvergate Bank
Mar 8, 2023 05:00PM MDxHealth Announces Update of Outstanding Shares and Voting Rights
Mar 8, 2023 04:00PM MDxHealth Reports Financial Year 2022 Results and Provides Business Update and Outlook for 2023
Mar 3, 2023 04:31PM MDxHealth (MDXH) Issues Shareholder Transparency Declarations
Mar 3, 2023 04:30PM MDxHealth Shareholder Transparency Declarations
Feb 28, 2023 04:30PM MDxHealth to Participate in 43rd Annual Cowen Healthcare Conference
Feb 22, 2023 04:30PM MDxHealth to Present Fourth Quarter and Full Year 2022 Financial Results on March 8, 2023
View Older Stories